Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipientsASBERG, A; HUMAR, A; ROLLAG, H et al.American journal of transplantation (Print). 2007, Vol 7, Num 9, pp 2106-2113, issn 1600-6135, 8 p.Article

An Assessment of Herpesvirus Co-infections in Patients with CMV Disease : Correlation with Clinical and Virologic OutcomesHUMAR, A; ASBERG, A; KUMAR, D et al.American journal of transplantation (Print). 2009, Vol 9, Num 2, pp 374-381, issn 1600-6135, 8 p.Article

Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant RecipientsASBERG, A; HUMAR, A; HARTMANN, A et al.American journal of transplantation (Print). 2009, Vol 9, Num 5, pp 1205-1213, issn 1600-6135, 9 p.Article